IRIS
LOMBARDI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.346
EU - Europa 4.127
AS - Asia 3.055
AF - Africa 129
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 6
Totale 15.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.214
SG - Singapore 1.471
CN - Cina 1.384
IT - Italia 691
DE - Germania 651
FI - Finlandia 613
SE - Svezia 536
IE - Irlanda 485
NL - Olanda 461
UA - Ucraina 295
GB - Regno Unito 153
CA - Canada 123
CI - Costa d'Avorio 118
RU - Federazione Russa 101
TR - Turchia 59
IN - India 57
FR - Francia 45
IR - Iran 24
BE - Belgio 21
EU - Europa 16
VN - Vietnam 16
CZ - Repubblica Ceca 14
ES - Italia 12
BR - Brasile 11
CO - Colombia 9
JP - Giappone 8
MX - Messico 8
CH - Svizzera 7
AR - Argentina 6
CL - Cile 6
EG - Egitto 6
PL - Polonia 6
RO - Romania 6
IQ - Iraq 5
KR - Corea 5
MY - Malesia 5
TH - Thailandia 5
AT - Austria 4
AU - Australia 4
DK - Danimarca 4
HK - Hong Kong 4
NO - Norvegia 4
EC - Ecuador 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
LT - Lituania 3
GE - Georgia 2
IL - Israele 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
DZ - Algeria 1
ID - Indonesia 1
KH - Cambogia 1
LK - Sri Lanka 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 15.717
Salva come PNG Salva come JPEG
Città #
Chandler 1.523
Singapore 1.185
Jacksonville 664
Millbury 597
Santa Clara 591
Princeton 510
Amsterdam 429
Nanjing 421
Wilmington 331
Ashburn 272
Naples 231
Beijing 196
Woodbridge 156
Nanchang 149
Boston 146
Helsinki 108
Ottawa 103
Norwalk 94
Shenyang 77
Ann Arbor 63
Hebei 62
Napoli 61
Jiaxing 60
Falls Church 56
Tianjin 53
Boardman 51
Houston 50
Kunming 49
Changsha 42
Kronberg 39
Moscow 37
Munich 35
Redwood City 34
Seattle 30
Indiana 29
Dublin 27
Washington 27
San Mateo 24
Pune 21
Shanghai 21
Lanzhou 20
Redmond 20
Ardabil 18
Augusta 18
Jinan 17
Los Angeles 17
Rome 17
Dallas 16
Des Moines 16
Dong Ket 16
Falkenstein 16
San Francisco 16
Toronto 15
Milan 14
New York 14
Frankfurt am Main 13
Guangzhou 13
Yellow Springs 13
Dearborn 12
Hangzhou 12
Tappahannock 12
Brno 11
Changchun 11
Istanbul 11
Zhengzhou 11
Leawood 10
Ningbo 10
Duncan 8
London 8
Sandston 8
Orange 7
Casoria 6
Courcelles 6
Paris 6
Casalbore 5
Fremont 5
Monfalcone 5
Simi Valley 5
Taizhou 5
Aracaju 4
Bangalore 4
Brussels 4
Chengdu 4
Clifton 4
Monmouth Junction 4
Oslo 4
Prineville 4
San Prisco 4
Torino 4
Venezia 4
Warsaw 4
Ankara 3
Basel 3
Buenos Aires 3
Chatsworth 3
Cleveland 3
Dogliani 3
Florence 3
Fuzhou 3
Heidelberg 3
Totale 9.192
Salva come PNG Salva come JPEG
Nome #
Systemic complications of acromegaly: epidemiology, pathogenesis, and management 399
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age 87
Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency 74
A protein family immunorelated to a sperm-binding protein and its regulation in human semen. 73
Antipituitary antibodies in idiopathic hyperprolactinemic patients 72
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women. 70
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 69
Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly 65
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 65
GH INSUFFICIENCY IN OBESE PATIENTS. 65
Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism 64
Correlation between Seminal Carnitine and Functional Spermatozoal Characteristics in Men with Semen Dysfunction of Various Origins 64
Weekly clodronate treatment prevents bone loss and vertebral fractures in womenwith subclinical Cushing's syndrome. 64
Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours 62
Sulfur amino acids in Cushing's disease: insight in homocysteine and taurine levels in patients with active and cured disease 61
Thyroid function and morphology after a successful kidney transplantation. 60
CORRELATION BETWEEN SEMINAL CARNITINE AND FUNCTIONAL CHARACTERISTICS IN MEN WITH SEMEN DYSFUNCTION OF VARIOUS ORIGINS. 60
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 60
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients 59
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 59
Subclinical hyperthyroidism: clinical features and treatment options. 58
Prolactin and prostate hypertrophy: a pilot observational, prospective, case-control study in men with prolactinoma 57
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 56
Cardiopulmonary impairment in young women with polycystic ovary syndrome 56
Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. 55
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 55
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I 54
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 54
Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy. 54
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 54
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. 54
Endocrine dysfunction in patients with Fabry disease 53
Effects of short-term treatment with orlistat on growth hormone/insulin-like growth factor-I axis in obese post-menopausal women. 53
Effects of neridronate treatment in elderly women with osteoporosis 52
Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy. 52
The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. 52
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 52
Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome. 52
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine 52
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. 52
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas. 51
Hypertension in acromegaly and in the normal population: prevalence and determinants 50
Advances in the treatment of prolactinomas 50
Cushing's syndrome 50
L'ESPOSIZIONE AMBIENTALE è UN FATTORE DI RISCHIO MASCHILE? 49
Identification and preliminary characterization of a sperm-binding protein in normal human semen 49
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. 49
Role of IGF-I on PTH effects on bone. 49
A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal. 49
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. 48
ANP, AVP, AND PITUITARY-THYROID AXIS IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ACUTE RESPIRATORY FAILURE. 48
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. 48
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial. 48
Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission 48
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. 48
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease 47
Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. 47
Alpha-melanocyte-stimulating hormone is present in the inferior petrosal sinuses in patients with Cushing's disease. 47
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling 47
Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency. 47
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours. 46
Cushing's syndrome: aftermath of the cure. 46
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas. 45
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas 45
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 45
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 45
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: A retrospective, comparative, head-to-head study 45
A reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index. 45
Limitations of Chromogranin A in clinical practice. 45
Appropriate use of stimulation tests and insulin-like growth factor-I in obesity 44
Acromegalic axial arthropathy: a clinical case-control study 44
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 44
Acute and chronic effects of human recombinant GH (hrGH) on adrenal steroidogenesis in children affected with isolated GH deficiency (IGHD) 44
Adjuvant Growth Hormone therapy in severely obese women with Growth Hormone Deficiency after Laparoscopic Adjustable Silicone Gastric Banding. 44
ASSOCIATION OF EARLY CAROTID ATHEROSCLEROSIS WITH HYPERINSULINEMIA AND LOW DHEA(S) IN NORMOTENSIVE SEVERE OBESE WOMEN. 44
Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. 44
Pegvisomant in acromegaly: why, when, how 43
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly 43
Growth hormone status in morbidly obese subjects and correlation with body composition 43
Altered glycosylation of pituitary gonadotropins in anorexia nervosa: an alternative explanation for amenorrhea 43
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 43
Cardiac effects of GH 43
Association of arginine vasopressin-secreting cell, steroid-secreting cell, adrenal and islet cell antibodies in a patient presenting with central diabetes insipidus, empty sella, subclinical adrenocortical failure and impaired glucose tolerance. 43
Complete disappearance of a GH-secreting pituitary macroadenoma in a patient with acromegaly: effect of treatment with lanreotide Autogel and consequence of treatment withdrawal. 43
Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients 43
Thyroid function in Fabry disease before and after enzyme replacement therapy. 43
Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. 42
A pilot study for neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase and 11-beta-hydroxylase deficiency in Campania region 42
An evaluation of patients with hyperprolactinemia: have dynamic tests had their day? 42
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency 42
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 42
Changes in insulin levels following 6-month treatment with recombinant human growth hormone in growth hormone-deficient adults. 42
Fertility in 32 patients receiving 131 I therapy for thyroid cancer 42
Effects of initial therapy for five years with somatostatin analogs foracromegaly on growth hormone and insulin-like growth factor-I levels, tumorshrinkage, and cardiovascular disease: a prospective study. 42
Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency 42
Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome 41
Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender 41
Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain 41
Acromegaly 41
Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. 41
Totale 5.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020727 0 0 0 0 0 7 10 8 7 89 180 426
2020/20211.219 22 62 151 72 66 286 85 28 122 66 198 61
2021/20223.273 55 22 18 39 83 331 44 109 507 258 591 1.216
2022/20233.422 572 318 114 292 403 341 18 264 458 444 154 44
2023/20242.044 91 354 322 145 75 153 34 219 17 36 357 241
2024/20252.572 604 790 41 102 315 720 0 0 0 0 0 0
Totale 16.154